Assignee
CELL SIGNALING TECHNOLOGY INC
US·41 granted patents·55 pending applications·308 citations·filing 1998–2022
Top patents by PatentIndex Score
96 records- 0195US7700339B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Apr 20, 2010·22 cites·15 claims
- 0293US7198896B2Immunoaffinity isolation of modified peptides from complex mixturesCELL SIGNALING TECHNOLOGY INC·Filed 2002·Granted Apr 3, 2007·62 cites·37 claims
- 0391US7259022B2Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 2001·Granted Aug 21, 2007·26 cites·14 claims
- 0490US6982318B1Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 2000·Granted Jan 3, 2006·25 cites·11 claims
- 0590US6441140B1Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 1998·Granted Aug 27, 2002·76 cites·5 claims
- 0689US8383799B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Feb 26, 2013·5 cites·5 claims
- 0789US8377642B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2010·Granted Feb 19, 2013·5 cites·36 claims
- 0888US10036756B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Jul 31, 2018·3 cites·16 claims
- 0988US7344714B2Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 2002·Granted Mar 18, 2008·16 cites·4 claims
- 1086US7183385B2Phospho-specific antibodies to Flt3 and uses thereofCELL SIGNALING TECHNOLOGY INC·Filed 2003·Granted Feb 27, 2007·40 cites·15 claims
- 1185US10551383B2Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Feb 4, 2020·2 cites·5 claims
- 1284US11377486B2Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residueCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jul 5, 2022·2 cites·6 claims
- 1382US10670606B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Jun 2, 2020·1 cites·20 claims
- 1482US9523130B2Methods of treating non-small cell lung carcinoma (NSCLC)CELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Dec 20, 2016·1 cites·29 claims
- 1580US9988688B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Jun 5, 2018·1 cites·15 claims
- 1678US9738711B2Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted Aug 22, 2017·2 cites·12 claims
- 1778US9181326B2Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2013·Granted Nov 10, 2015·2 cites·7 claims
- 1877US12577295B2Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residueCELL SIGNALING TECHNOLOGY INC·Filed 2022·Granted Mar 17, 2026·0 cites·9 claims
- 1977US11505833B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Nov 22, 2022·0 cites·10 claims
- 2076US7999080B2Reagents for the detection of protein phosphorylation in signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Aug 16, 2011·6 cites·2 claims
- 2176US7833736B2Protein markers of responsiveness to type III receptor tyrosine kinase inhibitorsCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Nov 16, 2010·5 cites·17 claims
- 2274US11761005B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Sep 19, 2023·0 cites·10 claims
- 2374US9328349B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted May 3, 2016·1 cites·32 claims
- 2474US7807789B2Reagents for the detection of protein phosphorylation in EGFR-signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Oct 5, 2010·1 cites·6 claims
- 2574US2022003771A1Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2673US10870892B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Dec 22, 2020·0 cites·12 claims
- 2773US2015184158A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2014·Application pending·0 cites
- 2872US7973134B2Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2006·Granted Jul 5, 2011·1 cites·3 claims
- 2972US2020363417A1Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 3071US11428696B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Aug 30, 2022·0 cites·19 claims
- 3170US10955416B2Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Mar 23, 2021·0 cites·9 claims
- 3269US7932044B2Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-αCELL SIGNALING TECHNOLOGY INC·Filed 2005·Granted Apr 26, 2011·2 cites·13 claims
- 3369US2022267854A1Egfr and ros1 kinase in cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3468US2021349095A1Ros kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3567US2018156802A1Methods of treating lung cancer by administration of an alk inhibitorCELL SIGNALING TECHNOLOGY INC·Filed 2017·Application pending·0 cites
- 3664US11352418B2Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jun 7, 2022·0 cites·8 claims
- 3764US11099188B2ROS kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Aug 24, 2021·0 cites·4 claims
- 3863US2020080159A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 3962US2021079445A1Multi Component DetectionCELL SIGNALING TECHNOLOGY INC·Filed 2020·Application pending·0 cites
- 4062US2014134640A1Gene Defects And Mutant ALK Kinase In Human Solid TumorsCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 4162US2013071841A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2012·Application pending·0 cites
- 4261US2016091493A1Method for predicting the response to her2-directed therapyCELL SIGNALING TECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 4360US10526661B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Jan 7, 2020·0 cites·17 claims
- 4460US7977462B2Tyrosine phosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Jul 12, 2011·1 cites·2 claims
- 4560US2016193208A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-alphaCELL SIGNALING TECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 4660US2003068652A1Positive identification of phospho-proteins using motif-specific, context-independent antibodies coupled with database searchingCELL SIGNALING TECHNOLOGY INC·Filed 2002·Application pending·0 cites
- 4759US9539254B2Mutant ROS expression in human cancerCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted Jan 10, 2017·0 cites·8 claims
- 4859US2013266965A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHACELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 4959US2011045534A1Nucleic Acid Cassette For Producing Recombinant AntibodiesCELL SIGNALING TECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 5059US2010216718A1Cancer Classification and Methods of UseCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CELL SIGNALING TECHNOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →